Antimony Corporation (UAMY) Benefited from the Export Restrictions

iMGP Global Partner, an investment management company, released its fourth quarter 2025 investor letter for the "iMGP Small Company Fund”. A copy of the letter can be downloaded here. The Fund returned 1.33% in the fourth quarter compared to the Russell 2000 Index’s 2.19% return. The Fund’s returns were flat at 0.01% in 2025, compared to a 12.81 return for the Index. In many respects, the market situation returned to normal in the fourth quarter. The Fund's poor performance in the fourth quarter was caused by the biotech businesses' impressive performance, which increased by more than 25%. The Fund generally avoids biotech stocks due to their extremely binary character. The majority of the year's underperformance happened in the third quarter due to style-related factors. Moving forward to 2026, the Fund hoped to continue to refine its process and improve its performance with a commitment to invest in high-quality, growing firms. Please review the Fund’s top five holdings to gain insights into their key selections for 2025.

In its fourth-quarter 2025 investor letter, iMGP Small Company Fund highlighted United States Antimony Corporation (AMEX:UAMY). United States Antimony Corporation (AMEX:UAMY) is a mining and specialty material company that operates in the Antimony and Zeolite segments. On March 09, 2026, United States Antimony Corporation (AMEX:UAMY) stock closed at $9.60 per share. One-month return of United States Antimony Corporation (AMEX:UAMY) was 17.79%, and its shares gained 566.67% over the past 52 weeks. United States Antimony Corporation (AMEX:UAMY) has a market capitalization of $1.344 billion.

iMGP Small Company Fund stated the following regarding United States Antimony Corporation (AMEX:UAMY) in its fourth quarter 2025 investor letter:

"United States Antimony Corporation (AMEX:UAMY) was a top contributor. UAMY has taken advantage of the export restrictions of antimony for military use out of China by winning a $245 million five-year sole source contract to rebuild the U.S. antimony supply. Given the volatility in the name and the speed at which it appreciated, along with further announcements of new antinomy processing investments by other players, we exited the name."

United States Antimony Corporation (AMEX:UAMY) is not on our list of 40 Most Popular Stocks Among Hedge Funds Heading Into 2026. According to our database, 18 hedge fund portfolios held United States Antimony Corporation (AMEX:UAMY) at the end of the fourth quarter, up from 12 in the previous quarter. While we acknowledge the potential of United States Antimony Corporation (AMEX:UAMY) as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

In another article, we covered United States Antimony Corporation (AMEX:UAMY) and shared a bullish thesis on the company. In addition, please check out our hedge fund investor letters Q4 2025 page for more investor letters from hedge funds and other leading investors.

READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money.

Disclosure: None. This article is originally published at Insider Monkey.